sample review
- Nichirei Biosciences anti-Zic2 antibody was used to perform immunohistochemistry in order to investigate the expression profiles of ZIC genes in brain tumors.
- Nichirei anti-CD8 antibody was used in immunohistochemistry to investigate the relationship between IDO expression and tumor-infiltrating lymphocytes in endometrial cancer.
- Nichirei Corp anti-S-100 antibody was used to perform immunohistochemistry in order to study the neuroendocrine differentiation of nasal and paranasal adenocarcinomas in dogs.
- Nichirei anti-CD34 antibody was used to staining MVD and perform immunohistochemical in order to study the detection of growth fraction.
- Nichirei anti-MART-1/Melan A antibody was used to perform immunohistochemistry in order to investigate the relationship between PEComas and CD1a expression.
- Nichirei Biosciences anti-vimentin antibody was used to perform immunohistochemistry in order to study the expression of the ZIC family genes in different type of brain tumors.
- Nichirei Biosciences anti-ZIC4 antibody was used to perform immunohistochemistry in order to study the expression of the ZIC family genes in different type of brain tumors.
- Nichirei Biosciences anti-ZIC antibody was used to perform immunohistochemistry in order to study the expression of the ZIC family genes in different type of brain tumors.
- NICHIREI Histofine Simple Stain MAX PO was used in immunohistochemistry in order to study the effect of nitric oxide on CXCR4 expression in papillary thyroid carcinoma and the correlation of CXCR4 expression with lymph node metastasis.
- Nichirei Bioscience Histofine Simple Stain MAX PO was used for immunohistochemical staining in order to identify biomarkers in ductal carcinoma in situ of the breast with microinvasion.
- Nichirei mouse anti-CD8+ monoclonal (clone C8/144B) antibody was used in immunohistochemistry to identify programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes as prognostic factors of human ovarian cancer
sample product